New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg - film coated tablet - 450 mg - active: valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg excipient: crospovidone microcrystalline cellulose opadry brown 15b565009 purified water stearic acid - for the treatment of cytomegalovirus (cmv) retinitis in acquired immunodeficiency syndrome (aids) patients. for the prevention of cmv disease in solid organ transplant patients at risk.

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - valganciclovir hydrochloride 496.3mg equivalent to 450 mg valganciclovir - film coated tablet - 450 mg - active: valganciclovir hydrochloride 496.3mg equivalent to 450 mg valganciclovir excipient: crospovidone microcrystalline cellulose opadry pink 15b24005 povidone stearic acid - valcyte is indicated for the treatment of cytomegalovirus (cmv) retinitis in acquired immunodeficiency syndrome (aids) patients. valcyte is indicated for the prevention of cmv disease in solid organ transplant patients at risk.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - valganciclovir hydrochloride - oral tablet - 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - valganciclovir hydrochloride - oral tablet - 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - valganciclovir hydrochloride - oral tablet - 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

torrent pharma (uk) ltd - valganciclovir hydrochloride - oral tablet - 450mg

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg - film coated tablet - 450 mg - active: valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg excipient: crospovidone microcrystalline cellulose opadry pink 80w540006 purified water stearic acid - apo-valgan is indicated for the treatment of cytomegalovirus (cmv) retinitis in acquired immunodeficiency syndrome (aids) patients.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - valganciclovir hydrochloride - oral tablet - 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva pharma uk ltd - valganciclovir hydrochloride - oral tablet - 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - valganciclovir hydrochloride - oral tablet - 450mg